MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 133 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $58,000 | -52.1% | 18,769 | -36.6% | 0.00% | – |
| Q4 2016 | $121,000 | -30.1% | 29,616 | +8.6% | 0.00% | – |
| Q3 2016 | $173,000 | +31.1% | 27,263 | +11.3% | 0.00% | – |
| Q2 2016 | $132,000 | -30.9% | 24,488 | +7.5% | 0.00% | – |
| Q1 2016 | $191,000 | +61.9% | 22,776 | +52.6% | 0.00% | – |
| Q4 2015 | $118,000 | -65.5% | 14,929 | -62.9% | 0.00% | -100.0% |
| Q3 2015 | $342,000 | -29.9% | 40,221 | +2.0% | 0.00% | 0.0% |
| Q2 2015 | $488,000 | +17.6% | 39,439 | +13.0% | 0.00% | 0.0% |
| Q1 2015 | $415,000 | -0.2% | 34,899 | -5.1% | 0.00% | 0.0% |
| Q4 2014 | $416,000 | +135.0% | 36,791 | +82.0% | 0.00% | – |
| Q3 2014 | $177,000 | +142.5% | 20,210 | +39.8% | 0.00% | – |
| Q1 2014 | $73,000 | -16.1% | 14,453 | -11.5% | 0.00% | – |
| Q4 2013 | $87,000 | +102.3% | 16,330 | +42.7% | 0.00% | – |
| Q3 2013 | $43,000 | – | 11,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 775,571 | $2,389,000 | 0.93% |
| KEMPNER CAPITAL MANAGEMENT INC. | 148,985 | $459,000 | 0.31% |
| Yakira Capital Management, Inc. | 248,420 | $765,000 | 0.27% |
| GARRISON BRADFORD & ASSOCIATES INC | 87,700 | $270,000 | 0.24% |
| Cannell & Co. | 1,212,478 | $3,734,000 | 0.13% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $180,000 | 0.13% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 726,000 | $2,236,000 | 0.12% |
| Virtus ETF Advisers LLC | 198,735 | $612,000 | 0.11% |
| STONERIDGE INVESTMENT PARTNERS LLC | 199,227 | $614,000 | 0.08% |
| Birchview Capital, LP | 44,000 | $136,000 | 0.08% |